Intarcia Logo  
CompanyPeopleProductsTechnologyMediaCareerscontact  
Abstract Image  
 

Duros Technology >

Patents

 

 

 

 


What is the DUROS® Technology?

The DUROS device is a subcutaneous osmotic mini-pump. Each device contains an appropriate volume of drug product to treat a patient for a predetermined extended duration of time.  The DUROS device is activated when subcutaneous tissue fluid passes through the device inlet, expanding the osmotic engine. The osmotic engine drives the piston at a constant rate, delivering consistent drug levels through the device outlet.  The DUROS device can be inserted in a subcutaneous space in various locations on the arms and abdomen during a reimbursable in-office procedure, in as little as 5 minutes by a physician or physician’s assistant, and ensures 100% patient adherence to therapy.  Delivering drugs via the DUROS technology avoids unwanted peak drug levels often associated with toxicities and sub-therapeutic troughs often associated with suboptimal therapeutic effects. Another key aspect of the DUROS technology is the unique formulations that maintain stability of proteins and peptides at human body temperature for extended periods of time.  This advance in formulations allows continuous delivery of effective therapy with less frequent administration thereby ensuring compliance and improving patient convenience.  The DUROS device was first FDA-approved as a drug delivery technology for a marketed commercial pharmaceutical in March 2000.

 

 
 
     
   
COMPANY | PEOPLE | PRODUCTS | TECHNOLOGY | MEDIA | CAREERS | CONTACT | HOME
© Intarcia Therapeutics, Inc. | Privacy Policy & Terms of Use